Fig. 2From: Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activitySeropositivity per specific ISP group. Seropositivity percentages of analyzed samples for A) ISP vs controls, B) specific ISP groups within the ISP group, with corresponding 95% CI’s. CI Confidence interval, ISP Immunosuppressant, TNF Tumor necrosis factorBack to article page